The “United States Cardiac Rhythm Management Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the United States Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers
The United States Cardiac Rhythm Management Devices Market report provides key information and data on:
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
- 2025 company share data for Cardiac Rhythm Management Devices Market.
- Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Cardiac Rhythm Management Devices is segmented as follows:
- Cardiac Resynchronisation Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICD)
- Pacemakers
Reasons to Buy
The United States Cardiac Rhythm Management Devices Market report helps you to develop:
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Rhythm Management Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
1.2 Cardiac Rhythm Management Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Rhythm Management Devices Market, North America
2.1 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2024-2036
2.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2024-2036
2.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
2.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
2.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2025
2.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2024-2036
2.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
2.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
2.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2025
3 Cardiac Rhythm Management Devices Market, Canada
3.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2024-2036
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036
3.4 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2025
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036
3.4 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2025
4 Cardiac Rhythm Management Devices Market, Mexico
4.1 Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2024-2036
4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2024-2036
4.4 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2025
4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2024-2036
4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2024-2036
4.4 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2025
5 Cardiac Rhythm Management Devices Market, United States
5.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2024-2036
5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2024-2036
5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2024-2036
5.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2024-2036
5.4 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2025
5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2024-2036
5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2024-2036
5.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2024-2036
5.4 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2025
6 Cardiac Rhythm Management Devices Market Pipeline Products
6.1 Cardiac Rhythm Management Devices Market Pipeline Products
6.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
6.3 Cardiac Rhythm Management Devices - Pipeline Products by Segment
6.4 Cardiac Rhythm Management Devices - Pipeline Products by Territory
6.5 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
6.6 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
6.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
6.3 Cardiac Rhythm Management Devices - Pipeline Products by Segment
6.4 Cardiac Rhythm Management Devices - Pipeline Products by Territory
6.5 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
6.6 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
7 Overview of Key Companies in North America Cardiac Rhythm Management Devices Market
7.1 Medtronic Plc
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Boston Scientific Corp
7.3.1 Company Overview
7.4 Biotronik SE & Co KG
7.4.1 Company Overview
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Boston Scientific Corp
7.3.1 Company Overview
7.4 Biotronik SE & Co KG
7.4.1 Company Overview
8 Recent Developments
8.1 Corporate Communications
8.1.1 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.1.2 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.1.3 Nov 10, 2025: TEDCO Announces Recent Company Formation and Technology Assessment Awardees
8.1.4 Nov 10, 2025: Dr. Felicitas Koller Named Inaugural Hardy-Raju Chair of Transplant Surgery
8.1.5 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.1.6 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms
8.1.7 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.1.8 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.9 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.10 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.11 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.12 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
8.1.13 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.14 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.1.15 Oct 20, 2025: Adagio Medical Secures $19 Million Financing to Enhance Ventricular Tachycardia Treatment Technology
8.1.16 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
8.1.17 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.18 Oct 06, 2025: Atacor Medical Secures $75 Million Financing for Pivotal U.S. Study of Extravascular ICD System
8.1.19 Oct 03, 2025: Ventripoint Extends and Upsizes Non-Brokered Convertible Debenture Private Placement
8.1.20 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts
8.1.21 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.22 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Apr 13, 2026: CVRx Reports Preliminary Q1 2026 Financial Results
8.2.2 Feb 24, 2026: Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
8.2.3 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.2.4 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.5 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.2.6 Nov 11, 2025: Stereotaxis Reports 2025 Third Quarter Financial Results
8.2.7 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.2.8 Oct 22, 2025: CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
8.2.9 Oct 14, 2025: Orthofix to Report Third Quarter 2025 Financial Results
8.2.10 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.11 Jul 31, 2025: iRhythm Technologies Announces Second Quarter 2025 Financial Results
8.2.12 Jul 15, 2025: Orthofix to Report Second Quarter 2025 Financial Results
8.3 Government and Public Interest
8.3.1 Dec 22, 2025: CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
8.3.2 Dec 18, 2025: EBR Systems to Present at J.P. Morgan 2026 Healthcare Conference
8.3.3 Nov 24, 2025: Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
8.3.4 Nov 19, 2025: CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
8.3.5 Nov 19, 2025: Ebr Systems To Participate At The Piper Sandler 37th Annual Healthcare Conference
8.3.6 Nov 19, 2025: EBR Systems to Participate at the Piper Sandler 37th Annual Healthcare Conference
8.3.7 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.3.8 Nov 04, 2025: CVRx To Present At The Jefferies Global Healthcare Conference In London
8.3.9 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.10 Oct 15, 2025: Orthofix to Participate in Upcoming Investor Conferences
8.3.11 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
8.3.12 Aug 20, 2025: iRhythm Technologies to Participate in Upcoming Investor Conferences
8.3.13 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
8.3.14 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.4 Legal And Regulatory
8.4.1 Jan 28, 2026: TRIPP-FFX Trial Completes Last Patient, Last Visit (LPLV)
8.4.2 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
8.5 Other Significant Developments
8.5.1 Feb 10, 2026: Orsobio Announces Positive Topline Phase 2A Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and Metabolic Liver Disease
8.5.2 Nov 25, 2025: Daxor Expands BVA Platform to Three Facilities and Deploys New Analyzer
8.5.3 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.5.4 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.5.5 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.5.6 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.5.7 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.8 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.5.9 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms
8.5.10 Nov 03, 2025: News Updates for Q3 2025
8.5.11 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.12 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
8.5.13 Oct 28, 2025: AtriCure Announces First Patient Treated in BoxX-NoAF Clinical Trial
8.5.14 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.5.15 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
8.5.16 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
8.5.17 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.5.18 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)
8.5.19 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
8.5.20 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program
8.5.21 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
8.5.22 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6 Product News
8.6.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
8.6.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.6.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.6.4 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.6.5 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.6.6 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
8.6.7 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.6.8 Nov 13, 2025: EnVVeno Faces FDA Rejection on VenoValve Application
8.6.9 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.6.10 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.6.11 Nov 11, 2025: AI/ML Innovations Announces Grant of U.S. Patent for ECG Signal-Processing Architecture
8.6.12 Nov 11, 2025: iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at Aha Scientific Sessions 2025
8.6.13 Nov 06, 2025: Artivion Treats First Patient in ARTIZEN Trial for Arcevo LSA
8.6.14 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.6.15 Nov 05, 2025: Fluid Control Solutions For MedTech
8.6.16 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome
8.6.17 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.6.18 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study
8.6.19 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
8.6.20 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.6.21 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
8.6.22 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.6.23 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
8.6.24 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.6.25 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.6.26 Oct 26, 2025: Real-World Data Presented at TCT 2025 Shows EggNest Complete Radiation Protection System Reduces Radiation Exposure for Cath Lab Team
8.6.27 Oct 24, 2025: Protaryx Medical Submits 510(k) Application for Next-Generation Transseptal Puncture Device
8.6.28 Oct 24, 2025: Pulse Biosciences Announces First Patient Enrollment in NANOCLAMP AF Study
8.6.29 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.6.30 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
8.6.31 Oct 22, 2025: Norav Medical Launches TeleEVENT - Full Disclosure Event Recorder for Remote Cardiac Telemetry
8.6.32 Oct 20, 2025: Adagio Medical Secures $19 Million Financing to Enhance Ventricular Tachycardia Treatment Technology
8.6.33 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
8.6.34 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
8.6.35 Oct 13, 2025: Stereotaxis And CardioFocus Collaborate To Advance Robotic Pulsed Field Ablation For Cardiac Arrhythmias
8.6.36 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.6.37 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
8.6.38 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.6.39 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
8.6.40 Oct 06, 2025: Atacor Medical Secures $75 Million Financing for Pivotal U.S. Study of Extravascular ICD System
8.6.41 Oct 06, 2025: QXMédical Announces Settlement With Teleflex, Clearing Path For U.S. Launch Of Boosting Catheter In 2026
8.6.42 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA
8.6.43 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
8.6.44 Sep 29, 2025: iHeartMedia and OSO Studios Launch Cardiac Cowboys Podcast Narrated by Chris Pine
8.6.45 Sep 25, 2025: FDA Clears EFAST Algorithm for Cardiovascular AI
8.6.46 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
8.6.47 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
8.6.48 Sep 17, 2025: AI Outperforms Doctors In Predicting Surgical Complications
8.6.49 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
8.6.50 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6.51 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment
8.6.52 Sep 09, 2025: HeartBeam Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG
8.7 Strategy And Business Planning
8.7.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
8.7.2 Nov 25, 2025: Daxor Expands BVA Platform to Three Facilities and Deploys New Analyzer
8.7.3 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.7.4 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.7.5 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.7.6 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.7.7 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
8.7.8 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.7.9 Oct 27, 2025: Cardiovascular Research Foundation Partners With Fogarty Innovation
8.7.10 Oct 13, 2025: Stereotaxis And CardioFocus Collaborate To Advance Robotic Pulsed Field Ablation For Cardiac Arrhythmias
8.7.11 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA
8.7.12 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo
8.7.13 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider
8.7.14 Sep 23, 2025: LogicMark Introduces Predictive Activity Metrics in Freedom Alert Max Device
8.7.15 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
8.7.16 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
8.1.1 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.1.2 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.1.3 Nov 10, 2025: TEDCO Announces Recent Company Formation and Technology Assessment Awardees
8.1.4 Nov 10, 2025: Dr. Felicitas Koller Named Inaugural Hardy-Raju Chair of Transplant Surgery
8.1.5 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.1.6 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms
8.1.7 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.1.8 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.9 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.10 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.11 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.12 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
8.1.13 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.14 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.1.15 Oct 20, 2025: Adagio Medical Secures $19 Million Financing to Enhance Ventricular Tachycardia Treatment Technology
8.1.16 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
8.1.17 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.18 Oct 06, 2025: Atacor Medical Secures $75 Million Financing for Pivotal U.S. Study of Extravascular ICD System
8.1.19 Oct 03, 2025: Ventripoint Extends and Upsizes Non-Brokered Convertible Debenture Private Placement
8.1.20 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts
8.1.21 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.22 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Apr 13, 2026: CVRx Reports Preliminary Q1 2026 Financial Results
8.2.2 Feb 24, 2026: Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
8.2.3 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.2.4 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.5 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.2.6 Nov 11, 2025: Stereotaxis Reports 2025 Third Quarter Financial Results
8.2.7 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.2.8 Oct 22, 2025: CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
8.2.9 Oct 14, 2025: Orthofix to Report Third Quarter 2025 Financial Results
8.2.10 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.11 Jul 31, 2025: iRhythm Technologies Announces Second Quarter 2025 Financial Results
8.2.12 Jul 15, 2025: Orthofix to Report Second Quarter 2025 Financial Results
8.3 Government and Public Interest
8.3.1 Dec 22, 2025: CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
8.3.2 Dec 18, 2025: EBR Systems to Present at J.P. Morgan 2026 Healthcare Conference
8.3.3 Nov 24, 2025: Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
8.3.4 Nov 19, 2025: CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
8.3.5 Nov 19, 2025: Ebr Systems To Participate At The Piper Sandler 37th Annual Healthcare Conference
8.3.6 Nov 19, 2025: EBR Systems to Participate at the Piper Sandler 37th Annual Healthcare Conference
8.3.7 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.3.8 Nov 04, 2025: CVRx To Present At The Jefferies Global Healthcare Conference In London
8.3.9 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.10 Oct 15, 2025: Orthofix to Participate in Upcoming Investor Conferences
8.3.11 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
8.3.12 Aug 20, 2025: iRhythm Technologies to Participate in Upcoming Investor Conferences
8.3.13 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
8.3.14 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.4 Legal And Regulatory
8.4.1 Jan 28, 2026: TRIPP-FFX Trial Completes Last Patient, Last Visit (LPLV)
8.4.2 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
8.5 Other Significant Developments
8.5.1 Feb 10, 2026: Orsobio Announces Positive Topline Phase 2A Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and Metabolic Liver Disease
8.5.2 Nov 25, 2025: Daxor Expands BVA Platform to Three Facilities and Deploys New Analyzer
8.5.3 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.5.4 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.5.5 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.5.6 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.5.7 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.8 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.5.9 Nov 05, 2025: Researcher Receives $2.6 Million Grant to Study Heartbeat Mechanisms
8.5.10 Nov 03, 2025: News Updates for Q3 2025
8.5.11 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.12 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
8.5.13 Oct 28, 2025: AtriCure Announces First Patient Treated in BoxX-NoAF Clinical Trial
8.5.14 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.5.15 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market
8.5.16 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
8.5.17 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.5.18 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)
8.5.19 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
8.5.20 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program
8.5.21 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
8.5.22 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6 Product News
8.6.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
8.6.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.6.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.6.4 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.6.5 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.6.6 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
8.6.7 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.6.8 Nov 13, 2025: EnVVeno Faces FDA Rejection on VenoValve Application
8.6.9 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.6.10 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.6.11 Nov 11, 2025: AI/ML Innovations Announces Grant of U.S. Patent for ECG Signal-Processing Architecture
8.6.12 Nov 11, 2025: iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at Aha Scientific Sessions 2025
8.6.13 Nov 06, 2025: Artivion Treats First Patient in ARTIZEN Trial for Arcevo LSA
8.6.14 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.6.15 Nov 05, 2025: Fluid Control Solutions For MedTech
8.6.16 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome
8.6.17 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.6.18 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study
8.6.19 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
8.6.20 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.6.21 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
8.6.22 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.6.23 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
8.6.24 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.6.25 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.6.26 Oct 26, 2025: Real-World Data Presented at TCT 2025 Shows EggNest Complete Radiation Protection System Reduces Radiation Exposure for Cath Lab Team
8.6.27 Oct 24, 2025: Protaryx Medical Submits 510(k) Application for Next-Generation Transseptal Puncture Device
8.6.28 Oct 24, 2025: Pulse Biosciences Announces First Patient Enrollment in NANOCLAMP AF Study
8.6.29 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.6.30 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
8.6.31 Oct 22, 2025: Norav Medical Launches TeleEVENT - Full Disclosure Event Recorder for Remote Cardiac Telemetry
8.6.32 Oct 20, 2025: Adagio Medical Secures $19 Million Financing to Enhance Ventricular Tachycardia Treatment Technology
8.6.33 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
8.6.34 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial
8.6.35 Oct 13, 2025: Stereotaxis And CardioFocus Collaborate To Advance Robotic Pulsed Field Ablation For Cardiac Arrhythmias
8.6.36 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.6.37 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
8.6.38 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.6.39 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit
8.6.40 Oct 06, 2025: Atacor Medical Secures $75 Million Financing for Pivotal U.S. Study of Extravascular ICD System
8.6.41 Oct 06, 2025: QXMédical Announces Settlement With Teleflex, Clearing Path For U.S. Launch Of Boosting Catheter In 2026
8.6.42 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA
8.6.43 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
8.6.44 Sep 29, 2025: iHeartMedia and OSO Studios Launch Cardiac Cowboys Podcast Narrated by Chris Pine
8.6.45 Sep 25, 2025: FDA Clears EFAST Algorithm for Cardiovascular AI
8.6.46 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
8.6.47 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment
8.6.48 Sep 17, 2025: AI Outperforms Doctors In Predicting Surgical Complications
8.6.49 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
8.6.50 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6.51 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment
8.6.52 Sep 09, 2025: HeartBeam Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG
8.7 Strategy And Business Planning
8.7.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland
8.7.2 Nov 25, 2025: Daxor Expands BVA Platform to Three Facilities and Deploys New Analyzer
8.7.3 Nov 13, 2025: HeartBeam Reports Third Quarter 2025 Results
8.7.4 Nov 11, 2025: iRhythm Technologies Publishes Large-Scale Study in Heart Rhythm and Presents New Data at AHA Scientific Sessions 2025
8.7.5 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.7.6 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.7.7 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica
8.7.8 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.7.9 Oct 27, 2025: Cardiovascular Research Foundation Partners With Fogarty Innovation
8.7.10 Oct 13, 2025: Stereotaxis And CardioFocus Collaborate To Advance Robotic Pulsed Field Ablation For Cardiac Arrhythmias
8.7.11 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA
8.7.12 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo
8.7.13 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider
8.7.14 Sep 23, 2025: LogicMark Introduces Predictive Activity Metrics in Freedom Alert Max Device
8.7.15 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial
8.7.16 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection
9 Appendix
9.1Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Table 5: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2025
Table 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036
Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036
Table 13: Pacemakers Market, Canada, Volume (Units), 2024-2036
Table 14: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036
Table 15: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 16: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 17: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 18: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 19: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 20: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2024-2036
Table 21: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2024-2036
Table 22: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2024-2036
Table 23: Pacemakers Market, Mexico, Volume (Units), 2024-2036
Table 24: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2024-2036
Table 25: Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 26: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 27: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 28: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 29: Pacemakers Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 30: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2024-2036
Table 31: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2024-2036
Table 32: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2024-2036
Table 33: Pacemakers Market, United States, Volume (Units), 2024-2036
Table 34: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2024-2036
Table 35: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 36: Cardiac Rhythm Management Devices Market Pipeline Products
Table 37: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 38: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 39: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 40: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 41: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 42: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 43: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Table 5: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2025
Table 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036
Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036
Table 13: Pacemakers Market, Canada, Volume (Units), 2024-2036
Table 14: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036
Table 15: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 16: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 17: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 18: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 19: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 20: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2024-2036
Table 21: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2024-2036
Table 22: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2024-2036
Table 23: Pacemakers Market, Mexico, Volume (Units), 2024-2036
Table 24: Cardiac Rhythm Management Devices Market, Mexico, Average Price ($), 2024-2036
Table 25: Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 26: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 27: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 28: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 29: Pacemakers Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 30: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2024-2036
Table 31: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2024-2036
Table 32: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2024-2036
Table 33: Pacemakers Market, United States, Volume (Units), 2024-2036
Table 34: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2024-2036
Table 35: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 36: Cardiac Rhythm Management Devices Market Pipeline Products
Table 37: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 38: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 39: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 40: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 41: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 42: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 43: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Figure 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Figure 5: Cardiac Rhythm Management Devices Market, North America, Company Share (%), 2025
Figure 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036
Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036
Figure 13: Pacemakers Market, Canada, Volume (Units), 2024-2036
Figure 14: Cardiac Rhythm Management Devices Market, Canada, Company Share (%), 2025
Figure 15: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 18: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 19: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2024-2036
Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2024-2036
Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2024-2036
Figure 22: Pacemakers Market, Mexico, Volume (Units), 2024-2036
Figure 23: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%), 2025
Figure 24: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 27: Pacemakers Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2024-2036
Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2024-2036
Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2024-2036
Figure 31: Pacemakers Market, United States, Volume (Units), 2024-2036
Figure 32: Cardiac Rhythm Management Devices Market, United States, Company Share (%), 2025
Figure 33: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 34: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 35: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 36: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 37: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Figure 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2024-2036
Figure 5: Cardiac Rhythm Management Devices Market, North America, Company Share (%), 2025
Figure 6: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 9: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 10: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036
Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036
Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036
Figure 13: Pacemakers Market, Canada, Volume (Units), 2024-2036
Figure 14: Cardiac Rhythm Management Devices Market, Canada, Company Share (%), 2025
Figure 15: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 18: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 19: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2024-2036
Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), 2024-2036
Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), 2024-2036
Figure 22: Pacemakers Market, Mexico, Volume (Units), 2024-2036
Figure 23: Cardiac Rhythm Management Devices Market, Mexico, Company Share (%), 2025
Figure 24: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 27: Pacemakers Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 28: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2024-2036
Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2024-2036
Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2024-2036
Figure 31: Pacemakers Market, United States, Volume (Units), 2024-2036
Figure 32: Cardiac Rhythm Management Devices Market, United States, Company Share (%), 2025
Figure 33: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 34: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 35: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 36: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 37: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corp
- Biotronik SE & Co KG
- MicroPort Scientific Corp
